Ajay V. Maker
University of California, San Francisco · 230 works · 6,078 citations · h-index 33
Top works
- Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4
- Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study
- Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma
- Analysis of the Cellular Mechanism of Antitumor Responses and Autoimmunity in Patients Treated with CTLA-4 Blockade
- Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma
- Management of Cancer Surgery Cases During the COVID-19 Pandemic: Considerations
- Gene-expression profiling to predict responsiveness to immunotherapy
- Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer
- Is Port Site Resection Necessary in the Surgical Management of Gallbladder Cancer?
- Therapeutic advances in anaplastic thyroid cancer: a current perspective
- Cytology from Pancreatic Cysts Has Marginal Utility in Surgical Decision-Making
- Regulatory T Cell Infiltration Predicts Outcome Following Resection of Colorectal Cancer Liver Metastases
- Can We Predict Which Residents Are Going to Pass/Fail the Oral Boards?
- Cyst Fluid Interleukin-1β (IL1β) Levels Predict the Risk of Carcinoma in Intraductal Papillary Mucinous Neoplasms of the Pancreas
- Survival after resection of cutaneous adnexal carcinomas with eccrine differentiation: Risk factors and trends in outcomes
- Pancreatic Cyst Fluid and Serum Mucin Levels Predict Dysplasia in Intraductal Papillary Mucinous Neoplasms of the Pancreas
- Cyst Fluid Biomarkers for Intraductal Papillary Mucinous Neoplasms of the Pancreas: A Critical Review from the International Expert Meeting on Pancreatic Branch-Duct-Intraductal Papillary Mucinous Neoplasms
- Selective Elimination of Human Regulatory T Lymphocytes In Vitro With the Recombinant Immunotoxin LMB-2
- The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform
- Loss of S100 antigenicity in metastatic melanoma